CNIH4 Antibodies

Santa Cruz Biotechnology offers a broad range of CNIH4 monoclonal antibodies for research applications. CNIH4 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CNIH4, or Cysteine-rich neurotrophic factor 4, plays a critical role in neuronal development and synaptic function. Research has shown CNIH4 involvement in the modulation of neurotransmitter signaling across multiple neural pathways. CNIH4 expression patterns have been linked to various neurological disorders, making it a significant target for neuroscience research. Understanding CNIH4 function and regulation provides valuable insights into neural development and potential therapeutic approaches. Investigating CNIH4 mechanisms continues to reveal new aspects of neurobiology and synaptic plasticity. CNIH4 research advances our understanding of neurological conditions and treatment strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing neuroscience discoveries and potential therapeutic developments.